Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) – Investment analysts at SVB Leerink increased their FY2020 EPS estimates for shares of Allscripts Healthcare Solutions in a research note issued on Tuesday, January 12th. SVB Leerink analyst S. Davis now anticipates that the software maker will post earnings per share of $0.51 for the year, up from their previous forecast of $0.49. SVB Leerink has a “Market Perform” rating and a $13.00 price objective on the stock. SVB Leerink also issued estimates for Allscripts Healthcare Solutions’ Q4 2020 earnings at $0.18 EPS.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings data on Tuesday, November 3rd. The software maker reported $0.20 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.19 by $0.01. Allscripts Healthcare Solutions had a negative net margin of 2.77% and a positive return on equity of 5.80%. The business had revenue of $402.00 million for the quarter, compared to analyst estimates of $419.75 million. During the same period last year, the business earned $0.17 EPS. The company’s revenue was down 9.7% on a year-over-year basis.

A number of other brokerages have also weighed in on MDRX. BidaskClub lowered shares of Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a report on Saturday, September 19th. JPMorgan Chase & Co. lowered shares of Allscripts Healthcare Solutions from a “neutral” rating to an “underweight” rating and raised their price objective for the company from $9.00 to $11.00 in a report on Friday, October 23rd. ValuEngine lowered shares of Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Monday, October 12th. Cantor Fitzgerald lifted their price target on shares of Allscripts Healthcare Solutions from $9.00 to $13.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 14th. Finally, Robert W. Baird lowered shares of Allscripts Healthcare Solutions from an “outperform” rating to a “neutral” rating and set a $13.00 price target on the stock. in a research note on Monday, October 19th. Six research analysts have rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $10.37.

Shares of MDRX opened at $16.17 on Thursday. Allscripts Healthcare Solutions has a twelve month low of $4.56 and a twelve month high of $16.30. The firm’s fifty day simple moving average is $14.45 and its 200-day simple moving average is $10.42. The firm has a market capitalization of $2.55 billion, a price-to-earnings ratio of -53.90, a PEG ratio of 3.17 and a beta of 1.17. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.85.

In other news, insider Lisa Khorey sold 15,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Wednesday, November 18th. The shares were sold at an average price of $12.75, for a total value of $191,250.00. Following the sale, the insider now owns 251,626 shares of the company’s stock, valued at $3,208,231.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Paul Black sold 60,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Monday, December 14th. The shares were sold at an average price of $14.03, for a total transaction of $841,800.00. The disclosure for this sale can be found here. 1.42% of the stock is owned by insiders.

A number of hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in Allscripts Healthcare Solutions by 4.5% during the second quarter. Vanguard Group Inc. now owns 17,719,701 shares of the software maker’s stock worth $119,963,000 after buying an additional 758,892 shares in the last quarter. Bank of America Corp DE boosted its holdings in Allscripts Healthcare Solutions by 10.4% during the second quarter. Bank of America Corp DE now owns 1,522,907 shares of the software maker’s stock worth $10,310,000 after buying an additional 143,593 shares in the last quarter. Nuveen Asset Management LLC boosted its holdings in Allscripts Healthcare Solutions by 9.4% during the second quarter. Nuveen Asset Management LLC now owns 1,514,410 shares of the software maker’s stock worth $10,252,000 after buying an additional 130,281 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in Allscripts Healthcare Solutions by 5.5% during the third quarter. Principal Financial Group Inc. now owns 1,460,964 shares of the software maker’s stock worth $11,892,000 after buying an additional 75,593 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its holdings in Allscripts Healthcare Solutions by 18.6% during the third quarter. Wells Fargo & Company MN now owns 979,074 shares of the software maker’s stock worth $7,970,000 after buying an additional 153,588 shares in the last quarter. 86.05% of the stock is currently owned by hedge funds and other institutional investors.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More: Understanding Compound Annual Growth Rate (CAGR)

Earnings History and Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.